Clinical Trial Record

Return to Clinical Trials

Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient


2023-09-01


2024-09-01


2025-09-01


450

Study Overview

Cross-sectional Survey on Palliative Therapy for Pancreatic Cancer Patient

It is a real-world observational cross-sectional follow-up study on clinical palliative care for pancreatic cancer patients in China. It is evaluated by an online questionnaire sent to the doctors from the General Surgery Department in more than 100 public tertiary teaching hospitals and about 350 public primary care units in the Chinese mainland.

Pancreatic cancer is a highly malignant gastrointestinal tumor with only a 10% overall 5-year survival rate. More than 80% of patients are already in the advanced stage when diagnosed, losing the chance of surgery. Advanced pancreatic cancer progresses rapidly and chemoradiotherapy has limited efficacy, so palliative care is thought to play an important role in the treatment process. However, due to the late development of palliative care, there is a lack of data on real-world clinical palliative care for pancreatic cancer patients in China. This study investigates the real-world current status of palliative care for pancreatic cancer patients by sending a web questionnaire to the doctors from the Department of General Surgery in more than 100 public tertiary teaching hospitals and about 350 public primary care units in the Chinese mainland. The survey aims to obtain the real status of palliative care and achieve a comprehensive understanding of how to develop palliative care in hospitals. The questionnaire includes both subjective standards like the surgeons' opinion on the development of palliative therapy and objective standards such as dedicated beds and teams for palliative care.

  • Pancreatic Cancer
  • OTHER: Observational study
  • K4602

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2023-10-03  

N/A  

2023-10-17  

2023-10-17  

N/A  

2023-10-19  

2023-10-19  

N/A  

2023-10  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
: Pancreatic cancer patients

OTHER: Observational study

  • Observational study
Primary Outcome MeasuresMeasure DescriptionTime Frame
Descriptions and scores of real status of hospice care in different hospitalsThe primary outcome is objective standards and subjective scores of current status of palliative care to qutify the development of palliative care of different hospitals. The score is evaluated by a follow-up questionnaire. The maximum and minimum score is 10 and 0, respectively.1 month
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Qiaofei Liu

Phone Number: 8615201693370

Email: qfliu@aliyun.com

Study Contact Backup

Name: Yuze Hua

Phone Number: 8617813719961

Email: huayuze97@163.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Doctors from the General Surgery Department in Chinese public tertiary teaching hospitals and public primary care units
  • Approval to participate
  • Participants with a valid and complete questionnaire evaluated by 2 experienced surgeons

  • Exclusion Criteria:

  • Refusal to participate
  • Participants with an invalid or incomplete questionnaire

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • STUDY_CHAIR: Qiaofei Liu, Department of General Surgery, Peking Union Medical College Hospital

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available